tiprankstipranks
Trending News
More News >
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Revenue

Compare
2,374 Followers

Aquestive Therapeutics Revenue

Aquestive Therapeutics had a revenue of 12.81M in the quarter ending Sep 30, 2025, with 28.03%. This bring the company's revenue in the last twelve months to 43.40M, Increased -1.67%. In the fiscal year ending Dec 31, 2024, Aquestive Therapeutics had annual revenue of 57.56M with 13.80% growth.
Revenue (ttm)
43.40M
Revenue Growth
-26.32%
P/S Ratio
12.65
Revenue/Employee
$405,359
Employees
142
Market Cap
$728.36M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
57.56M6.98M+113.80%
Dec 31, 2023
50.58M2.90M+106.09%
Dec 31, 2022
47.68M-3.15M+93.80%
Dec 31, 2021
50.83M4.98M+110.87%
Dec 31, 2020
45.85M-6.76M+87.15%
Dec 31, 2019
52.61M-14.82M+78.02%
Dec 31, 2018
67.43M512.00K+100.77%
Dec 31, 2017
66.92M15.13M+129.22%
Dec 31, 2016
51.78M